SP

Suhas Popatlal Shah

Director Director DIN 02059966
DIN 02059966 First appointment Jul 2003 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2003
Shareholding value •••• Premium profile

About Suhas Popatlal Shah

Data last updated:

Suhas Popatlal Shah was a Director at Omni-Protech Drugs Private Limited (2003–2008) and Director at H. M. & Company Medisales Private Limited (2011–2014). The companies operate in Pharma.

DIN 02059966
Primary Designation Director
Industry Pharma
First Appointment 20 Jul 2003

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Omni-Protech Drugs Private Limited U24239PN1993PTC071120
Director20 Jul 20031993₹24.63 Cr (FY 2025)Active
Director20 Jun 20112011Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Omni-Protech Drugs Private Limited
H. M. & Company Medisales Private Limited
Premium access

Shareholding and investment profile for Suhas Popatlal Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suhas Popatlal Shah

Suhas Popatlal Shah was first appointed on 20 Jul 2003 as Director at Omni-Protech Drugs Private Limited. The most recent appointment on record is 20 Jun 2011 at H. M. & Company Medisales Private Limited.

Suhas Popatlal Shah held 2 earlier board appointments: Omni-Protech Drugs Private Limited (Director, 20 Jul 2003 to 27 Dec 2008); H. M. & Company Medisales Private Limited (Director, 20 Jun 2011 to 01 Jan 2014).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available